We are live on ! Find out more
EC

EJF Capital Portfolio holdings

AUM $142M
1-Year Est. Return 23.3%
This Fund
S&P 500
This Quarter Est. Return
+8.52%
1 Year Est. Return
+23.3%
3 Year Est. Return
+101.54%
5 Year Est. Return
+62.43%
10 Year Est. Return
+246.47%
AUM
$1.12B
AUM Growth
-$22.3M
Cap. Flow
-$151M
Cap. Flow %
-13.41%
Top 10 Hldgs %
43.59%
Holding
389
New
53
Increased
70
Reduced
45
Closed
98

Sector Composition

Rank Sector Weight
1 Financials 89.58%
2 Industrials 1.62%
3 Consumer Discretionary 1.41%
4 Energy 1.29%
5 Communication Services 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANAC.WS
276
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$4K ﹤0.01%
4,658
HIIIW
277
DELISTED
Hudson Executive Investment Corp. III Warrant
HIIIW
$4K ﹤0.01%
5,529
DHBCW
278
DELISTED
DHB Capital Corp. Warrant
DHBCW
$4K ﹤0.01%
6,666
RCHGW
279
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$4K ﹤0.01%
9,154
STRE.WS
280
DELISTED
Supernova Partners Acquisition Company III, Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
STRE.WS
$4K ﹤0.01%
+4,000
New +$3.72K
BNAIW
281
Brand Engagement Network Warrant
BNAIW
$1.97M
$3K ﹤0.01%
6,666
CVIIW
282
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$3K ﹤0.01%
3,199
-3,340
-51% -$3.63K
TRCA.WS
283
DELISTED
Twin Ridge Capital Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TRCA.WS
$3K ﹤0.01%
5,000
PSAGW
284
DELISTED
Property Solutions Acquisition Corporation II Warrant
PSAGW
$3K ﹤0.01%
+5,000
New +$3.67K
CAS.WS
285
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
$2K ﹤0.01%
5,000
AEON icon
286
AEON Biopharma
AEON
$12.9M
-375
Closed -$263K
OSG
287
Octave Specialty Group
OSG
$243M
-967,808
Closed -$13.9M
BLND icon
288
Blend Labs
BLND
$431M
-70,100
Closed -$945K
BTMD icon
289
Biote Corp
BTMD
$68.2M
-23,936
Closed -$233K
C icon
290
Citigroup
C
$222B
-15,000
Closed -$1.05M
CARV
291
DELISTED
Carver Bancorp
CARV
-155,337
Closed -$2.77M
COIN icon
292
Coinbase
COIN
$38.5B
-1,000
Closed -$227K
DKNG icon
293
DraftKings
DKNG
$11.6B
-20,000
Closed -$963K
FBNC icon
294
First Bancorp
FBNC
$2.6B
-70,559
Closed -$3.04M
FBP icon
295
First Bancorp
FBP
$4.42B
-822,208
Closed -$10.8M
FCEL icon
296
FuelCell Energy
FCEL
$1.73B
-21,667
Closed -$4.35M
FGBI icon
297
First Guaranty Bancshares
FGBI
$159M
-122,984
Closed -$2.24M
GM icon
298
General Motors
GM
$80.4B
-5,000
Closed -$264K
HIPO icon
299
Hippo Holdings
HIPO
$830M
-4,000
Closed -$468K
IBOC icon
300
International Bancshares
IBOC
$4.76B
-129,780
Closed -$5.4M

Similar funds

EJF Capital's Q4 2021 Portfolio in Review

As of Q4 2021, EJF Capital held 389 positions worth $1.12B, down 1.9% from $1.15B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

EJF Capital withdrew a net $151M in Q4 2021, closing 98 positions and reducing 45 holdings. Its most notable exit was Octave Specialty Group, an estimated $13.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 90% of assets, up from 89% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, EJF Capital opened a new position in Affirm worth $28.7M.

  • EJF Capital's largest Q4 2021 buy was Affirm: 285,000 shares worth $28.7M.
  • EJF Capital added most to OneMain Financial in Q4 2021, an estimated $72.6M increase.
  • EJF Capital's biggest Q4 2021 reduction was Silvergate Capital Corporation, cutting an estimated $89.5M.
  • EJF Capital fully exited Octave Specialty Group in Q4 2021, selling an estimated $13.9M.
  • EJF Capital's ten largest holdings make up 44% of its $1.12B portfolio in Q4 2021.
  • EJF Capital opened 53 new positions and closed 98 in Q4 2021.
  • EJF Capital's portfolio value fell 1.9% quarter-over-quarter to $1.12B.

Based on EJF Capital's 13F filing for Q4 2021, filed 11 Feb 2022.